Face Transplant: Current Update and First Canadian Experience.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
01 May 2021
Historique:
entrez: 23 4 2021
pubmed: 24 4 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Facial vascularized composite allotransplantation has emerged as a groundbreaking reconstructive solution for patients with severely disfiguring facial injuries. The authors report on the first Canadian face transplant. A 64-year-old man sustained a gunshot wound, which resulted in extensive midface bony and soft-tissue damage involving the lower two-thirds of the face. In May of 2018, he underwent a face transplant consisting of Le Fort III and bilateral sagittal split osteotomies in addition to skin from the lower two-thirds of the face and neck. Virtual surgical planning was used to fabricate osteotomy guides and stereolithographic models. Microsurgical anastomoses of the facial (three branches) and infraorbital nerves were performed bilaterally. At 18-month follow-up, the aesthetic outcome was excellent. Partial restoration of light touch sensation had been observed over the majority of the allograft. Although significantly affected, animation, speech, mastication, and deglutition were continuously improving with intensive therapy. Nevertheless, the patient was now tracheostomy and gastrostomy free. Despite these limitations, he reported a high degree of satisfaction with the procedure and had reintegrated into the community. Four grade I episodes of acute rejection with evidence of endotheliitis were successfully treated. Postoperative complications were mainly infectious, including mucormycosis of the left thigh, treated with surgical resection and antifungal therapy. Undoubtedly, immunosuppression represents the greatest obstacle in the field and limits the indications for facial vascularized composite allotransplantation. Continuous long-term follow-up is mandatory for surveillance of immunosuppression-related complications and functional assessment of the graft.

Identifiants

pubmed: 33890901
doi: 10.1097/PRS.0000000000007890
pii: 00006534-202105000-00026
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1177-1188

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 by the American Society of Plastic Surgeons.

Déclaration de conflit d'intérêts

Disclosure:The authors have no conflicts of interest to declare. A research grant was donated by Johnson & Johnson.

Références

Devauchelle B, Badet L, Lengelé B, et al. First human face allograft: Early report. Lancet 2006;368:203–209.
Sosin M, Rodriguez ED. The face transplantation update: 2016. Plast Reconstr Surg. 2016;137:1841–1850.
Lantieri L, Grimbert P, Ortonne N, et al. Face transplant: Long-term follow-up and results of a prospective open study. Lancet 2016;388:1398–1407
Razonable RR, Amer H, Mardini S. Application of a new paradigm for cytomegalovirus disease prevention in Mayo Clinic’s first face transplant. Mayo Clin Proc. 2019;94:166–170.
Lassus P, Lindford A, Vuola J, et al. The Helsinki face transplantation: Surgical aspects and 1-year outcome. J Plast Reconstr Aesthet Surg. 2018;71:132–139.
Ramly EP, Kantar RS, Diaz-Siso JR, Alfonso AR, Rodriguez ED. Computerized approach to facial transplantation: Evolution and application in 3 consecutive face transplants. Plast Reconstr Surg Glob Open 2019;7:e2379.
Koenig D. First African American face transplant performed. Available at: https://www.webmd.com/a-to-z-guides/news/20191028/first-african-american-face-transplant-performed . Accessed November 20, 2019.
Cabrera AE, Kimberly LL, Kantar RS, et al. Perceived esthetic outcomes of face transplantation: A survey of the general public. J Craniofac Surg. 2018;29:848–851.
Aduen JF, Sujay B, Dickson RC, et al. Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc. 2009;84:973–978.
Dorafshar AH, Bojovic B, Christy MR, et al. Total face, double jaw, and tongue transplantation: An evolutionary concept. Plast Reconstr Surg. 2013;131:241–251.
Roche NA, Vermeersch HF, Stillaert FB, et al. Complex facial reconstruction by vascularized composite allotransplantation: The first Belgian case. J Plast Reconstr Aesthet Surg. 2015;68:362–371.
Lantieri L. Face transplant: A paradigm change in facial reconstruction. J Craniofac Surg. 2012;23:250–253.
Rodríguez-Lorenzo A, Audolfsson T, Wong C, Saiepour D, Nowinski D, Rozen S. Vascular perfusion of the facial skin: Implications in allotransplantation of facial aesthetic subunits. Plast Reconstr Surg. 2016;138:1073–1079.
Van Lierde KM, De Letter M, Vermeersch H, et al. Longitudinal progress of overall intelligibility, voice, resonance, articulation and oromyofunctional behavior during the first 21 months after Belgian facial transplantation. J Commun Disord. 2015;53:42–56.
Maciejewski A, Krakowczyk Ł, Szymczyk C, et al. The first immediate face transplant in the world. Ann Surg. 2016;263:e36–e39.
Aycart MA, Kiwanuka H, Krezdorn N, et al. Quality of life after face transplantation: Outcomes, assessment tools, and future directions. Plast Reconstr Surg. 2017;139:194–203.
Roy SF, Krishnan V, Trinh VQ, et al. Lymphocytic vasculitis associated with mild rejection in a vascularized composite allograft recipient: A clinicopathological study. Transplantation 2020;104:e208–e213.

Auteurs

Alexander Govshievich (A)

From Maisonneuve Rosemont Hospital.

Eli Saleh (E)

From Maisonneuve Rosemont Hospital.

Elie Boghossian (E)

From Maisonneuve Rosemont Hospital.

Suzon Collette (S)

From Maisonneuve Rosemont Hospital.

Delphine Desy (D)

From Maisonneuve Rosemont Hospital.

Simon Dufresne (S)

From Maisonneuve Rosemont Hospital.

Helen St-Jacques (H)

From Maisonneuve Rosemont Hospital.

Andre Chollet (A)

From Maisonneuve Rosemont Hospital.

Dominique Tremblay (D)

From Maisonneuve Rosemont Hospital.

Charles Guertin (C)

From Maisonneuve Rosemont Hospital.

Michele Tardif (M)

From Maisonneuve Rosemont Hospital.

Jean Poirier (J)

From Maisonneuve Rosemont Hospital.

Tareck Ayad (T)

From Maisonneuve Rosemont Hospital.

Akram Rahal (A)

From Maisonneuve Rosemont Hospital.

Daniel E Borsuk (DE)

From Maisonneuve Rosemont Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH